DermaCompare: "designed to revolutionize the process of diagnosing melanoma" (...Really ?)

Out of Israel, DermaCompare, a market-centric spin off from Esmeral Medical, is promoting a Cloud-based sophisticated image processing technology fro skin imaging. The skin lesions detection software solution is designed to revolutionize the process of diagnosing  melanoma, the major cause of skin cancer related mortality. 

DermaCompare supports early stage diagnosis of skin cancer by providing constant monitoring of suspicious skin lesions using various  imaging methods, thereby significantly increasing the chances of treating the condition, as well as lowering the cost and complexity of treatment.


The product is not FDA approved and detailed information / case studies / performance of the system is not very accessible. We would love to know more ( leave a comment).

Their YouTube clip provides some fuzzy screen captures, some insights on the technology platform ( " we use aerial defense technology to save 420 million people from skin cancer") but does not discuss clinical efficacy nor business models.